Skip to main content
OpenTrials
Completed

NCT Number: NCT01512719

POEM- Peroral Endoscopic Myotomy for Esophageal Motility Disorders

POEM has recently described as an alternative treatment for achalasia in humans. In this procedure the esophageal sphincter is incised through a submucosal tunnel in the esophagus. In this study we aim to perform POEM on achalasia patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hadassah Medical Center, Jerusalem, Israel

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with Achalasia whom are candidates for Heller Myotomy

Exclusion criteria

  • Perforation of LES during dilatation
  • Pregnant women
  • mentally ill patients

Treatment and study plan

POEM

Procedure

Per Oral Endoscopic Myotomy for achalasia

Primary outcomes

  1. Resolution of dysphagia

    Time frame: up to 6 months postoperatively

Sponsors and collaborators

Lead sponsor

Hadassah Medical Organization

Other

Registry information

Official study title

POEM a Novel Endoscopic Treatment for Achalasia

Acronym: POEM

Important dates

Study start
2013
Primary completion
2023
Study completion
2023
First posted
Jan 19, 2012
Registry last updated
Oct 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.